Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery

Overview

Journal J Ophthalmol

Publisher Wiley

Specialty Ophthalmology

Date 2018 Oct 2

PMID 30271631

Citations 6

Authors

Lei Zuo

Jianhong Zhang

Xun Xu

Affiliations

Soon will be listed here.

Abstract

The present study aimed at observing the effect of a single subconjunctival injection of bevacizumab (BVZ) combined with 5-fluorouracil (5-Fu) or mitomycin C (MMC) on the antiscarring effect of glaucoma filtration surgery (GFS). The inhibitory effect of combined BVZ and 5-Fu in retinal pigment epithelial cells on vascular endothelial growth factor (VEGF) levels was demonstrated through experiments. Combined BVZ and 5-Fu and combined BVZ and MMC inhibited cell cycle, induced apoptosis, and inhibited human umbilical vein endothelial cell migration. Also, the cytotoxicity of combined BVZ and 5-Fu was lower. In animal experiments, the observation of filtering bleb survival, hematoxylin and eosin and Masson staining of filtering bleb scars, and mRNA expression levels of fibrosis markers in filtering blebs showed that combined BVZ and 5-Fu had a better antiscarring effect compared with single drugs; however, the antiscarring effect of combined BVZ and MMC was not significantly different from MMC. Therefore, the findings of this study provided more reference for the clinical use of adjuncts to inhibit scarring after GFS and helped understand the regulatory effect of combined anti-VEGF antibody BVZ and antimetabolites on wound healing more comprehensively.

Citing Articles

17β-estradiol inhibits TGF-β-induced collagen gel contraction mediated by human Tenon fibroblasts Smads and MAPK signaling pathways.

Yang C, Liu M, Li Y, Xu Z, Liu Y, Guo Z Int J Ophthalmol. 2023; 16(9):1441-1449.

PMID: 37724268 PMC: 10475634. DOI: 10.18240/ijo.2023.09.10.

Anti-scarring effects of conbercept on human Tenon's fibroblasts: comparisons with bevacizumab.

Zuo L, Zhu S, Gu S, Xu X BMC Ophthalmol. 2023; 23(1):183.

PMID: 37101202 PMC: 10131424. DOI: 10.1186/s12886-023-02914-4.

Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery.

Shao C, Sinha N, Mohan R, Webel A Biomedicines. 2023; 11(3.

PMID: 36979636 PMC: 10045591. DOI: 10.3390/biomedicines11030657.

Wound Healing Response After Bleb-Forming Glaucoma Surgery With a SIBS Microshunt in Rabbits.

van Mechelen R, Wolters J, Herfs M, Bertens C, Gijbels M, Pinchuk L Transl Vis Sci Technol. 2022; 11(8):29.

PMID: 36018582 PMC: 9428362. DOI: 10.1167/tvst.11.8.29.

Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts.

Fan Gaskin J, Kong R, Shah M, Edgley A, Peshavariya H, Chan E Transl Vis Sci Technol. 2022; 11(8):18.

PMID: 35980669 PMC: 9404366. DOI: 10.1167/tvst.11.8.18.

References

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View

Campochiaro P . Ocular versus extraocular neovascularization: mirror images or vague resemblances. Invest Ophthalmol Vis Sci. 2006; 47(2):462-74. DOI: 10.1167/iovs.05-1494. View

Wang A, Landen N, Meisgen F, Lohcharoenkal W, Stahle M, Sonkoly E . MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. PLoS One. 2014; 9(7):e103206. PMC: 4113372. DOI: 10.1371/journal.pone.0103206. View

Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M . Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009; 50(11):5217-25. DOI: 10.1167/iovs.08-2662. View

Murakami M, Iwai S, Hiratsuka S, Yamauchi M, Nakamura K, Iwakura Y . Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages. Blood. 2006; 108(6):1849-56. DOI: 10.1182/blood-2006-04-016030. View

Skuta G, Parrish 2nd R . Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987; 32(3):149-70. DOI: 10.1016/0039-6257(87)90091-9. View

Seibold L, Sherwood M, Kahook M . Wound modulation after filtration surgery. Surv Ophthalmol. 2012; 57(6):530-50. DOI: 10.1016/j.survophthal.2012.01.008. View

Grehn F, Hollo G, Khaw P, Overton B, Wilson R, Vogel R . Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152. Ophthalmology. 2007; 114(10):1831-8. DOI: 10.1016/j.ophtha.2007.06.028. View

Steindl-Kuscher K, Krugluger W, Boulton M, Haas P, Schrattbauer K, Feichtinger H . Activation of the beta-catenin signaling pathway and its impact on RPE cell cycle. Invest Ophthalmol Vis Sci. 2009; 50(9):4471-6. DOI: 10.1167/iovs.08-3139. View

10.

Lama P, Fechtner R . Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003; 48(3):314-46. DOI: 10.1016/s0039-6257(03)00038-9. View

11.

Smith S, DAmore P, Dreyer E . Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol. 1994; 118(3):332-7. DOI: 10.1016/s0002-9394(14)72957-5. View

12.

Schwartz K, Budenz D . Current management of glaucoma. Curr Opin Ophthalmol. 2004; 15(2):119-26. DOI: 10.1097/00055735-200404000-00011. View

13.

Tong J, Lam D, Chan W, Choy K, Chan K, Pang C . Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells. Mol Vis. 2006; 12:1490-5. View

14.

Yan Z, Bai Y, Tian Z, Hu H, You X, Lin J . Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery. Mol Vis. 2011; 17:2495-506. PMC: 3185021. View

15.

Zhong H, Sun G, Lin X, Wu K, Yu M . Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci. 2011; 52(6):3136-42. DOI: 10.1167/iovs.10-6240. View

16.

Kim M, Lee C, Payne R, Yue B, Chang J, Ying H . Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review. Surv Ophthalmol. 2015; 60(6):524-35. PMC: 4615284. DOI: 10.1016/j.survophthal.2015.04.003. View

17.

Skuta G, Beeson C, Higginbotham E, Lichter P, Musch D, Bergstrom T . Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992; 99(3):438-44. DOI: 10.1016/s0161-6420(92)31951-7. View

18.

Vinores S, Chan C, Vinores M, Matteson D, Chen Y, Klein D . Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. J Neuroimmunol. 1998; 89(1-2):43-50. DOI: 10.1016/s0165-5728(98)00075-7. View

19.

Burr J, Azuara-Blanco A, Avenell A . Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2005; (2):CD004399. DOI: 10.1002/14651858.CD004399.pub2. View

20.

Fitzpatrick T, Lash G, Yanaihara A, Charnock-Jones D, Macdonald-Goodfellow S, Graham C . Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. Exp Cell Res. 2003; 283(2):247-55. DOI: 10.1016/s0014-4827(02)00044-7. View